Abstract
Australian and U.S. researchers have shown that a small molecule inhibitor of RNA polymerase I blocked tumor growth in mouse models of lymphoma. Cylene Pharmaceuticals and the Peter MacCallum Cancer Centre plan to start a Phase I trial of the inhibitor in Australia this year.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
